Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 31–45 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5395 ATP7A Gene Occipital Horn Syndrome Genetic Test This test identifies pathogenic variants in the ATP7A gene associated with Occipital Horn Syndrome (OHS).	Peripheral Blood (EDTA), Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP7A gene sequence", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling session"] Indications ["Suspected Occipital Horn Syndrome (OHS)", "Family history of OHS", "Carrier testing for at-risk family members", "Differential diagnosis of copper transport disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81247-8 ICD-10: E83.0 Clinical summary This test identifies pathogenic variants in the ATP7A gene associated with Occipital Horn Syndrome (OHS).
TEST-3759 ATRX Gene Alpha-Thalassemia/Mental Retardation Syndrome Genetic Test This test evaluates the ATRX gene for pathogenic variants associated with Alpha-Thalassemia/Mental Retardation Syndrome (ATR-X). It uses Next-Generation Sequencing (NGS) with Copy...	Whole Blood (EDTA) or Saliva (Oragene)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATRX gene", "Copy Number Variants (CNVs) in the ATRX gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current anticoagulant use"] Indications ["Suspected Alpha-Thalassemia/Mental Retardation Syndrome (ATR-X)", "Family history of ATR-X", "Evaluation of intellectual disability with associated features"] Measurement technique Confirm with laboratory Codes LOINC: 81663-8 ICD-10: Q87.8, D56.0, Z13.7 Clinical summary This test evaluates the ATRX gene for pathogenic variants associated with Alpha-Thalassemia/Mental Retardation Syndrome (ATR-X). It uses Next-Generation Sequencing (NGS) with Copy Number Variant (CNV) analysis.
TEST-6317 AVP Gene (Arginine Vasopressin) Neurohypophyseal Diabetes Insipidus Genetic Test (NGS) This test evaluates the AVP gene for mutations causing inherited neurohypophyseal diabetes insipidus.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AVP gene mutations", "Copy Number Variants (CNVs) in AVP gene"] Parameters [] Preparation ["Pre-test genetic counseling session required", "No specific fasting or medication adjustments needed"] Indications ["Suspected familial neurohypophyseal diabetes insipidus", "Differentiation from nephrogenic or primary polydipsia disorders", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 89283-2 ICD-10: E23.2 Clinical summary This test evaluates the AVP gene for mutations causing inherited neurohypophyseal diabetes insipidus.
TEST-5739 B4GALNT1 Gene SPG26 Genetic Test This test evaluates the entire B4GALNT1 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 26 (SPG26).	Peripheral whole blood (3–5 mL in EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants (SNVs, small indels, copy number variations) in the B4GALNT1 gene", "Full gene coverage (coding exons ± flanking intronic regions)"] Parameters [] Preparation [] Indications ["Patients with clinical spastic paraplegia", "Family history of SPG26", "Carrier testing"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: G11.4 Clinical summary This test evaluates the entire B4GALNT1 gene for pathogenic variants associated with Hereditary Spastic Paraplegia Type 26 (SPG26).
TEST-3691 B9D2 Gene Meckel Syndrome Type 10 Next-Generation Sequencing (NGS) Genetic Test This test identifies pathogenic variants in the B9D2 gene associated with Meckel syndrome type 10.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B9D2 gene", "Copy Number Variations (CNV) in the B9D2 gene"] Parameters [] Preparation [] Indications ["Diagnosis of Meckel syndrome type 10", "Carrier screening for Meckel syndrome type 10", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 92822-6 ICD-10: Q61.9 Clinical summary This test identifies pathogenic variants in the B9D2 gene associated with Meckel syndrome type 10.
TEST-3947 BBS4 Gene Bardet-Biedl Syndrome Type 4 Genetic Test This test identifies pathogenic variants in the BBS4 gene, confirming Bardet-Biedl syndrome type 4.	Whole Blood or Buccal Swab	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BBS4 gene", "Copy Number Variations (CNV) in BBS4"] Parameters [] Preparation ["No fasting required"] Indications ["Family history of Bardet-Biedl syndrome type 4", "Clinical features suggestive of Bardet-Biedl syndrome type 4"] Measurement technique Confirm with laboratory Codes LOINC: 92810-9 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the BBS4 gene, confirming Bardet-Biedl syndrome type 4.
TEST-4704 BCS1L Gene Leigh Syndrome Genetic Test This genetic test identifies pathogenic variants within the BCS1L gene associated with Leigh syndrome.	Whole Blood, Extracted DNA, or FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BCS1L gene", "Mitochondrial function related to BCS1L protein"] Parameters [] Preparation ["No specific fasting required.", "Inform the phlebotomist of any current medications."] Indications ["Suspected Leigh syndrome based on clinical presentation", "Family history of Leigh syndrome or related mitochondrial disorders", "Need for definitive molecular diagnosis to guide treatment and counselling"] Measurement technique Confirm with laboratory Codes LOINC: 88312-2 ICD-10: G31.82 Clinical summary This genetic test identifies pathogenic variants within the BCS1L gene associated with Leigh syndrome.
TEST-2486 BRAF Gene Noonan Syndrome Type 7 Genetic Test (NGS) This test identifies pathogenic variants in the BRAF gene associated with Noonan syndrome type 7.	Blood, Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRAF gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Suspected Noonan syndrome type 7", "Family history of Noonan syndrome type 7"] Measurement technique Confirm with laboratory Codes LOINC: 79328-3 ICD-10: Q87.1, Z13.79, Z82.79 Clinical summary This test identifies pathogenic variants in the BRAF gene associated with Noonan syndrome type 7.
TEST-4953 BRWD3 Gene X-Linked Intellectual Disability Type 93 Genetic Test This test identifies pathogenic variants within the BRWD3 gene associated with X-linked intellectual disability type 93.	Whole blood (peripheral)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRWD3 gene pathogenic variants", "Missense mutations", "Nonsense mutations", "Splice-site mutations", "Small insertions/deletions"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspected X-linked intellectual disability type 93", "Family history of X-linked intellectual disability", "Carrier screening in female relatives"] Measurement technique Confirm with laboratory Codes LOINC: 101357-0 ICD-10: F78.9 Clinical summary This test identifies pathogenic variants within the BRWD3 gene associated with X-linked intellectual disability type 93.
TEST-6169 C12ORF65 Gene Combined Oxidative Phosphorylation Deficiency Type 7 Genetic Test This genetic test detects pathogenic variants in the C12ORF65 gene, confirming a diagnosis of Combined Oxidative Phosphorylation Deficiency Type 7.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C12ORF65 gene", "Cellular energy production disruption"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Suspected Combined Oxidative Phosphorylation Deficiency Type 7", "Confirmation of clinical diagnosis", "Metabolic management guidance", "Family planning decisions"] Measurement technique Confirm with laboratory Codes LOINC: 94828-4 ICD-10: E88.8 Clinical summary This genetic test detects pathogenic variants in the C12ORF65 gene, confirming a diagnosis of Combined Oxidative Phosphorylation Deficiency Type 7.
TEST-6209 CA12 Gene Hyperchlorhidrosis, Isolated Genetic Test This test evaluates the entire coding region of the CA12 gene for variants associated with isolated hyperchlorhidrosis.	Whole Blood (PBMC) or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA12 gene variants", "Sweat chloride regulation pathway"] Parameters [] Preparation ["Pre-test genetic counselling required", "Provide a three-generation family pedigree"] Indications ["Definitive diagnosis of isolated hyperchlorhidrosis", "Family screening for CA12 variants", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 48000-0 ICD-10: E88.8 Clinical summary This test evaluates the entire coding region of the CA12 gene for variants associated with isolated hyperchlorhidrosis.
TEST-4694 CA2 Gene Osteopetrosis (Autosomal Recessive Type 3) Genetic Test This test identifies mutations in the CA2 gene associated with autosomal recessive osteopetrosis type 3.	Whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA2 gene mutations", "DNA sequence variants"] Parameters [] Preparation [] Indications ["Suspected autosomal recessive osteopetrosis type 3", "Family planning for carrier couples", "Evaluation of bone fragility"] Measurement technique Confirm with laboratory Codes LOINC: 55132-0 ICD-10: Q78.2 Clinical summary This test identifies mutations in the CA2 gene associated with autosomal recessive osteopetrosis type 3.
TEST-4012 CA8 Gene Test for Cerebellar Ataxia & Mental Retardation (CAMRQ3) This genetic test identifies mutations in the CA8 gene associated with Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome 3 (CAMRQ3). It uses next-generation sequen...	Whole blood (EDTA), extracted DNA, or dry blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA8 gene variants", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation [] Indications ["Diagnostic confirmation of CAMRQ3", "Carrier testing", "Family risk assessment", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 83006-7 ICD-10: G11.8, F79, Z15.89 Clinical summary This genetic test identifies mutations in the CA8 gene associated with Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome 3 (CAMRQ3). It uses next-generation sequencing to analyze the entire coding region of the gene.
TEST-5331 CASP8 Gene Autoimmune Lymphoproliferative Syndrome Type 2B Genetic Test This test identifies pathogenic variants in the CASP8 gene associated with Autoimmune Lymphoproliferative Syndrome Type 2B (ALPS-2B).	Peripheral whole blood (EDTA)	3–4 Weeks (expedited 2‑week option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CASP8 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "≥99.9%"}, {"name": "Analytical Specificity", "reference_range": "≥99.9%"}, {"name": "Variant Types Detected", "reference_range": "SNVs, indels, CNVs"}] Preparation ["No fasting required", "Formal genetic counseling session mandatory", "Detailed pedigree chart required", "Complete clinical history required", "List all medications/supplements", "Avoid blood transfusions for at least 2 weeks prior"] Indications ["Unexplained lymphoproliferation", "Autoimmune cytopenias", "Family history of ALPS"] Measurement technique Confirm with laboratory Codes LOINC: 88151-2 ICD-10: D89.82, Z13.5 Clinical summary This test identifies pathogenic variants in the CASP8 gene associated with Autoimmune Lymphoproliferative Syndrome Type 2B (ALPS-2B).
TEST-5725 CATSPER2 Gene (Deafness & Male Infertility) Genetic Test This test evaluates the CATSPER2 gene for pathogenic variants associated with autosomal recessive syndromic hearing loss and male sterility.	Peripheral Whole Blood or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CATSPER2 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Provide detailed personal and family history of hearing loss/infertility", "Provide a pedigree chart during pre-test genetic counseling"] Indications ["Individuals with combined congenital sensorineural deafness and male infertility", "Family history suggestive of Deafness-Infertility Syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: H90.5, N46.9 Clinical summary This test evaluates the CATSPER2 gene for pathogenic variants associated with autosomal recessive syndromic hearing loss and male sterility.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.